![[Valid RSS]](/images/valid-rss.png "Validate my RSS feed"){kind=small}
![[Valid Atom]](/images/valid-atom.png "Validate my Atom feed"){kind=small}
Kyphon’s an interesting stock; big employers seek more purchasing clout
Kyphon (KYPH), a maker of instruments for minimally invasive spine surgery and a cement used in spine surgery, is an interesting stock that’s being recommended by more securities analysts. A CBSMarketwatch.com chart is here. And the company’s profiled in the June issue of Health Care Strategic Management. The issue’s Market Memo is “Neurosciences provide great opportunities for hospitals,” and my column discusses how “Big employers seek more purchasing clout” under the guise of seeking to help the uninsured obtain health insurance.
Kyphon (KYPH), a maker of instruments for minimally invasive spine surgery and a cement used in spine surgery, is an interesting stock that’s being recommended by more securities analysts. A CBSMarketwatch.com chart is here. And the company’s profiled in the June issue of Health Care Strategic Management. The issue’s Market Memo is “Neurosciences provide great opportunities for hospitals,” and my column discusses how “Big employers seek more purchasing clout” under the guise of seeking to help the uninsured obtain health insurance.
Next entry: Challenger promises more spending on Canadian health care
Previous entry: Too much technology in health care?